Microfluidics for Medicine
Event details
| Date | 10.08.2018 |
| Hour | 14:00 › 15:30 |
| Speaker | Prof. Xingyu Jiang, National Center for Nanoscience and Technology, Beijing (China) |
| Location | |
| Category | Conferences - Seminars |
BIOENGINEERING SEMINAR
Abstract:
Microfluidics represent an appealing platform for biochemical assays and discovery of new therapeutics (such as medical implants and drugs). We demonstrate that microfluidics can dramatically improve the efficiency of these assays and screens. Driven by miniaturization and surface chemistry, microscale-chips allow the assays of clinically important biomarkers such as proteins, nucleic acids and cells, with improved throughput, sensitivity and stability. Combined with nanoparticles and nanomaterials, microfluidics show great promise in developing novel assays and realizing point-of-care testing. These platforms are also extraordinarily useful for screening of therapeutics, e.g., nanocarriers for introducing siRNA, CRISPR/Cas, and so forth.
Bio:
Xingyu Jiang is a Chair Professor at the Southern University of Science and Technology, Shenzhen, China. He obtained his BS at the University of Chicago (1999) and PhD at Harvard University (with Prof. George Whitesides, 2004). In 2005, he joined the National Center for NanoScience and Technology and the University of the Chinese Academy of Sciences. He joined the Southern University of Science and Technology in 2018. His research interests include microfluidics and nanomedicine. He was awarded the “Hundred Talents Plan” of the Chinese Academy of Sciences, the National Science Foundation of China’s Distinguished Young Scholars Award, the Scopus Young Researcher Gold Award, the Human Frontier Science Program Young Investigator Award. He is a Fellow of the Royal Society of Chemistry, an associate editor of Nanoscale (Royal Society of Chemistry, UK).
Abstract:
Microfluidics represent an appealing platform for biochemical assays and discovery of new therapeutics (such as medical implants and drugs). We demonstrate that microfluidics can dramatically improve the efficiency of these assays and screens. Driven by miniaturization and surface chemistry, microscale-chips allow the assays of clinically important biomarkers such as proteins, nucleic acids and cells, with improved throughput, sensitivity and stability. Combined with nanoparticles and nanomaterials, microfluidics show great promise in developing novel assays and realizing point-of-care testing. These platforms are also extraordinarily useful for screening of therapeutics, e.g., nanocarriers for introducing siRNA, CRISPR/Cas, and so forth.
Bio:
Xingyu Jiang is a Chair Professor at the Southern University of Science and Technology, Shenzhen, China. He obtained his BS at the University of Chicago (1999) and PhD at Harvard University (with Prof. George Whitesides, 2004). In 2005, he joined the National Center for NanoScience and Technology and the University of the Chinese Academy of Sciences. He joined the Southern University of Science and Technology in 2018. His research interests include microfluidics and nanomedicine. He was awarded the “Hundred Talents Plan” of the Chinese Academy of Sciences, the National Science Foundation of China’s Distinguished Young Scholars Award, the Scopus Young Researcher Gold Award, the Human Frontier Science Program Young Investigator Award. He is a Fellow of the Royal Society of Chemistry, an associate editor of Nanoscale (Royal Society of Chemistry, UK).
Practical information
- Informed public
- Free
Organizer
Contact
- Institute of Bioengineering (IBI, Dietrich REINHARD)